HEADER TRANSFERASE 02-JUN-10 3NB7 TITLE CRYSTAL STRUCTURE OF AQUIFEX AEOLICUS PEPTIDOGLYCAN TITLE 2 GLYCOSYLTRANSFERASE IN COMPLEX WITH DECARBOXYLATED NERYL MOENOMYCIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: PENICILLIN-BINDING PROTEIN 1A; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 59-243; COMPND 5 SYNONYM: PBP-1A, PBP1A, PENICILLIN-INSENSITIVE TRANSGLYCOSYLASE, COMPND 6 PEPTIDOGLYCAN TGASE, PENICILLIN-SENSITIVE TRANSPEPTIDASE, DD- COMPND 7 TRANSPEPTIDASE; COMPND 8 EC: 2.4.2.-; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: AQUIFEX AEOLICUS; SOURCE 3 ORGANISM_TAXID: 63363; SOURCE 4 STRAIN: VF5; SOURCE 5 GENE: AQ_624, MRCA, PONA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET48 B(+) KEYWDS GLYCOSYLTRANSFERASES, PEPTIDOGLYCAN GLYCOSYLTRANSFERASE, KEYWDS 2 POLYSACCHARIDES, CELL WALL, ANTIBIOTICS, MOENOMYCIN, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR P.SLIZ,Y.YUAN,S.WALKER REVDAT 2 06-SEP-23 3NB7 1 SEQADV REVDAT 1 18-MAY-11 3NB7 0 JRNL AUTH S.FUSE,H.TSUKAMOTO,Y.YUAN,T.S.WANG,Y.ZHANG,M.BOLLA,S.WALKER, JRNL AUTH 2 P.SLIZ,D.KAHNE JRNL TITL FUNCTIONAL AND STRUCTURAL ANALYSIS OF A KEY REGION OF THE JRNL TITL 2 CELL WALL INHIBITOR MOENOMYCIN. JRNL REF ACS CHEM.BIOL. V. 5 701 2010 JRNL REFN ISSN 1554-8929 JRNL PMID 20496948 JRNL DOI 10.1021/CB100048Q REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH Y.YUAN,S.FUSE,B.OSTASH,P.SLIZ,D.KAHNE,S.WALKER REMARK 1 TITL STRUCTURAL ANALYSIS OF THE CONTACTS ANCHORING MOENOMYCIN TO REMARK 1 TITL 2 PEPTIDOGLYCAN GLYCOSYLTRANSFERASES AND IMPLICATIONS FOR REMARK 1 TITL 3 ANTIBIOTIC DESIGN REMARK 1 REF ACS CHEM.BIOL. V. 3 429 2008 REMARK 1 REFN ISSN 1554-8929 REMARK 1 PMID 18642800 REMARK 2 REMARK 2 RESOLUTION. 2.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.38 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 125502.460 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.6 REMARK 3 NUMBER OF REFLECTIONS : 7916 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.233 REMARK 3 FREE R VALUE : 0.271 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.300 REMARK 3 FREE R VALUE TEST SET COUNT : 500 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.012 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.65 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.82 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 80.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1032 REMARK 3 BIN R VALUE (WORKING SET) : 0.4000 REMARK 3 BIN FREE R VALUE : 0.3680 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 6.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 68 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.045 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1441 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 74.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -16.41000 REMARK 3 B22 (A**2) : -27.07000 REMARK 3 B33 (A**2) : 43.48000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.39 REMARK 3 ESD FROM SIGMAA (A) : 0.68 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.44 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.67 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 20.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.820 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.380 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.430 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.840 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.990 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 46.35 REMARK 3 REMARK 3 NCS MODEL : NONE REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 3 : WATER_REP.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 BULK SOLVENT MODEL USED. THE STRUCTURE OF DECARBOXYLATED REMARK 3 NERYL MOENOMYCIN IS NOT MODELED IN BECAUSE OF LOW OCCUPANCY, REMARK 3 BUT THE ELECTRON DENSITY MAP CLEARLY SHOWS THE DENSITY OF REMARK 3 THE LIGAND, ESPECIALLY THE PHOSPHATE ATOM, IN THE LIGAND REMARK 3 BINDING SITE REMARK 4 REMARK 4 3NB7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-JUN-10. REMARK 100 THE DEPOSITION ID IS D_1000059610. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8408 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.650 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06100 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 2OQO REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.54 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.28 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM HEPES, 6% PEG6K, PH 7.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 27.13350 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 50.24650 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 51.31150 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 27.13350 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 50.24650 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 51.31150 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 27.13350 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 50.24650 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 51.31150 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 27.13350 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 50.24650 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 51.31150 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2260 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17330 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -17.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 54.26700 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 100.49300 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 44 REMARK 465 PRO A 45 REMARK 465 GLY A 46 REMARK 465 TYR A 47 REMARK 465 GLN A 48 REMARK 465 ASP A 49 REMARK 465 PRO A 50 REMARK 465 LYS A 51 REMARK 465 GLY A 52 REMARK 465 ARG A 53 REMARK 465 LEU A 54 REMARK 465 TYR A 55 REMARK 465 GLY A 56 REMARK 465 THR A 57 REMARK 465 ILE A 58 REMARK 465 ASN A 105 REMARK 465 TYR A 106 REMARK 465 ARG A 107 REMARK 465 ALA A 108 REMARK 465 GLY A 109 REMARK 465 ARG A 110 REMARK 465 ILE A 111 REMARK 465 VAL A 112 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 61 3.45 -171.59 REMARK 500 LYS A 62 35.57 -69.19 REMARK 500 PHE A 64 68.78 82.48 REMARK 500 ASP A 84 73.00 -156.27 REMARK 500 ILE A 103 -76.50 -41.71 REMARK 500 ARG A 130 63.05 -115.12 REMARK 500 ALA A 202 88.42 -172.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 METHYLPHOSPHORYL NERYL MOENOMYCIN WAS NOT MODELED IN THE COMPLEX REMARK 600 STRUCTURE BECAUSE OF LOW OCCUPANCY REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2OQO RELATED DB: PDB REMARK 900 RELATED ID: 3D3H RELATED DB: PDB REMARK 900 RELATED ID: 3NB6 RELATED DB: PDB DBREF 3NB7 A 51 243 UNP O66874 PBPA_AQUAE 51 243 SEQADV 3NB7 GLY A 44 UNP O66874 EXPRESSION TAG SEQADV 3NB7 PRO A 45 UNP O66874 EXPRESSION TAG SEQADV 3NB7 GLY A 46 UNP O66874 EXPRESSION TAG SEQADV 3NB7 TYR A 47 UNP O66874 EXPRESSION TAG SEQADV 3NB7 GLN A 48 UNP O66874 EXPRESSION TAG SEQADV 3NB7 ASP A 49 UNP O66874 EXPRESSION TAG SEQADV 3NB7 PRO A 50 UNP O66874 EXPRESSION TAG SEQRES 1 A 200 GLY PRO GLY TYR GLN ASP PRO LYS GLY ARG LEU TYR GLY SEQRES 2 A 200 THR ILE GLY ILE GLN LYS ARG PHE TYR VAL SER ILE ASP SEQRES 3 A 200 LYS ILE PRO GLU HIS VAL ILE ASN ALA PHE VAL ALA THR SEQRES 4 A 200 GLU ASP ARG ASN PHE TRP HIS HIS PHE GLY ILE ASP PRO SEQRES 5 A 200 VAL ALA ILE VAL ARG ALA ALA ILE VAL ASN TYR ARG ALA SEQRES 6 A 200 GLY ARG ILE VAL GLN GLY GLY SER THR ILE THR GLN GLN SEQRES 7 A 200 LEU ALA LYS ASN LEU PHE LEU THR ARG GLU ARG THR LEU SEQRES 8 A 200 GLU ARG LYS ILE LYS GLU ALA LEU LEU ALA ILE LYS ILE SEQRES 9 A 200 GLU ARG THR PHE ASP LYS LYS LYS ILE MET GLU LEU TYR SEQRES 10 A 200 LEU ASN GLN ILE TYR LEU GLY SER GLY ALA TYR GLY VAL SEQRES 11 A 200 GLU ALA ALA ALA GLN VAL TYR PHE GLY LYS HIS VAL TRP SEQRES 12 A 200 GLU LEU SER LEU ASP GLU ALA ALA LEU LEU ALA ALA LEU SEQRES 13 A 200 PRO LYS ALA PRO ALA LYS TYR ASN PRO PHE TYR HIS PRO SEQRES 14 A 200 GLU ARG ALA LEU GLN ARG ARG ASN LEU VAL LEU LYS ARG SEQRES 15 A 200 MET LEU GLU GLU GLY TYR ILE THR PRO GLU GLN TYR GLU SEQRES 16 A 200 GLU ALA VAL ASN LYS HELIX 1 1 SER A 67 ILE A 71 5 5 HELIX 2 2 PRO A 72 ASP A 84 1 13 HELIX 3 3 ASP A 94 VAL A 104 1 11 HELIX 4 4 THR A 117 ASN A 125 1 9 HELIX 5 5 THR A 133 PHE A 151 1 19 HELIX 6 6 ASP A 152 ILE A 164 1 13 HELIX 7 7 TYR A 171 GLY A 182 1 12 HELIX 8 8 HIS A 184 LEU A 188 5 5 HELIX 9 9 SER A 189 ALA A 198 1 10 HELIX 10 10 HIS A 211 GLU A 229 1 19 HELIX 11 11 THR A 233 LYS A 243 1 11 CRYST1 54.267 100.493 102.623 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018427 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009951 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009744 0.00000